HIGHLIGHTS from SABCS: New HER2 Antibody-drug Conjugate Yielded Promising Clinical Responses in Breast Cancer Patients Pre-treated with T-DM1

Watch Now HIGHLIGHTS from SABCS: New HER2 Antibody-drug Conjugate Yielded Promising Clinical Responses in Breast Cancer Patients Pre-treated with T-DM1

HIGHLIGHTS from SABCS: Phase III SOPHIA study: HER2+metastatic breast cancer interim overall survival analysis

Watch Now HIGHLIGHTS from SABCS: Phase III SOPHIA study: HER2+metastatic breast cancer interim overall survival analysis

HIGHLIGHTS from SABCS: Assessing immune biomarkers of response to anthracyclines in breast cancer

Watch Now HIGHLIGHTS from SABCS: Assessing immune biomarkers of response to anthracyclines in breast cancer

HIGHLIGHTS from SABCS: The Genomic Landscape of Male Breast Cancers using the Oncomine Comprehensive Assay for Actionable Mutations.

Watch Now HIGHLIGHTS from SABCS: The Genomic Landscape of Male Breast Cancers using the Oncomine Comprehensive Assay for Actionable Mutations.

KEYNOTE-119: Phase 3 study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple-negative breast cancer (mTNBC).

Watch Now KEYNOTE-119: Phase 3 study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple-negative breast cancer (mTNBC).